The premise is straightforward — we are awash in biological data. The rapid growth of multiomics datasets (genomics, transcriptomics, proteomics, metabolomics, and radiomics) together with ...
NEW YORK--(BUSINESS WIRE)--The Food Allergy Fund (FAF) today convened scientists, investors, policymakers, and advocates at its annual Summit in New York City, unveiling advances that mark a pivotal ...
The U.S. Food and Drug Administration (FDA) recently launched a drug repurposing initiative that may signal a shift in how ...
CSIR-IICT scientists have used AI-driven structural bioinformatics to identify a promising repurposed drug candidate against poxviruses, including Mpox and Lumpy Skin Disease Virus.
Owkin and Sanofi are expanding their artificial intelligence collaboration through a multi-year agreement to co-develop AI-enabled biopharma agents for drug research and development. Under the new ...
The FDA is seeking public comments on drugs that could be candidates for a new use through its reurposing initiative. The FDA is looking to get thrifty with its approved drugs. Through a newly ...
With the help of artificial intelligence, a coalition of Bay Area institutions identified 18 FDA-approved drugs that could improve the lives of those suffering from amyotrophic lateral sclerosis, ...
The US Food and Drug Administration (FDA) has issued a warning letter to Purolea Cosmetics Lab for several violations of Good Manufacturing Practices (GMP). Notably, the warning letter calls the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results